Event Details

Toco-X-Krill Available Here

Discover Toco-X-Krill: Superior tocotrienols (super vitamin E) with added krill oil

Heather Schofield, B.Sc, DHMHS, HD.  

Hosted by:

Heather Schofield, B.Sc., DHMHS

Medical Educational Director

  Dr. Wael Massrieh  


Dr. Wael Massrieh, Ph.D.

Neptune Technologies & Bioresources

  Prof. Chandan Sen  


Dr. Chandan K Sen

Ohio State University, Medical Center for Carotech, Inc.

Presented by: Dr. Wael Massrieh, Ph.D. from Neptune Technologies & Bioresourcs and Prof. Dr. Chandan Sen from Ohio State University, Medical Center for Carotech, Inc.

The New Vitamin Supplement of the 21st Century: Discover the World’s First Tocomin SupraBio tocotrienols and NKO Krill oil Blend!

Terra-Medica is excited to announce the launch of our new product, Toco-X-Krill. Join Dr. Wael Massrieh, Ph.D. and Prof. Dr. Chandan Sen to learn about the vast and unique benefits of Toco-X-Krill.

Tocomin SupraBio® (full spectrum tocotrienols) derived from red palm oil and NKO® (Neptune Krill Oil) derived from Antarctic krill are rigorously researched with strong scientific validation for safety, efficacy and proven health benefits. Highlights of this powerful combination - exclusive natural vitamin E (full spectrum tocotrienols) and krill oil - include: superior cardiovascular, brain, neurological and skin protection; liver health, cholesterol management, anti-aging; potent antioxidant and anti-inflammatory properties.

Toco-X-Krills's Unique Characteristics:

  • Quality Matters: The type of vitamin E and Omega 3 you take is very important - tocotrienols molecular structure and patented self emulsification system, and krill oil's phosphorylated DHA and EPA enhance transportation into the cell membranes and delivery to targeted organs including: heart, liver, skin, adipose and the brain. Clinical Studies: Supports health claims and specific dosing recommendations.
  • Increased Absorption through a Patented Delivery System: Greatest bioavailability, absorption and assimilate of tocotrienols and Omega 3s (DHA and EPA) available on the market
  • Superior Antioxidant Potency: Provides protection against oxidation, free radical damage and lipid peroxidation
  • Ethically Sourced from Nature with sustainability as top priority!

Bio Dr. Wael Massrieh:

Dr. Wael Massrieh joined Neptune in 2007 and currently holds the position of Vice President of Scientific affairs. He completed his Bachelors of Science in Microbiology and Immunology at McGill University, where he then pursued his Doctorate in Medicine, in the division of Experimental Medicine specializing in proteins that regulate inflammation. He has received several well recognized scholarships and awards for his work on pro-inflammatory cytokines and transcription factors in premature labor, including the McGill Majors J.W. MCCONELL Memorial Fellowship as well as the CIHR Cancer Consortium Studentship. Dr. Massrieh is published multiple times in peer reviewed publications and has presented at numerous international conferences. His interest in Omega-3 research started during his doctorate, after several articles had shown that there was link between diets that were low in Omega-3 fatty acids and increased risk of preterm birth. This eventually introduced him to Neptune’s krill oil and its rich source of novel generation of omega-3. Ever since, he has been devoted to the research and development of Neptune Krill Oil and furthering its penetration into the dietary supplements, functional foods and Pharmaceutical markets.

Bio Dr. Chandan K Sen:

Dr. Chandan K Sen is a tenured Professor of Surgery, Executive Director of The Ohio State University Comprehensive Wound Center and Director of the Ohio State University's Center for Regenerative Medicine & Cell Based Therapies. He is also the Associate Dean for Research at The Ohio State University Wexner Medical Center. Dr. Sen directs the Medical Center's Technology Commercialization and Industry Partnership program and serves as a program director (Innovation & Collaboratory) for The Ohio State University's Center for Clinical and Translational Science . Dr. Sen represents Medicine and Health Sciences in President Gee's Global Gateway initiative (see video link below).

After completing his Masters of Science in Human Physiology from the University of Calcutta, Dr. Sen received his PhD in Physiology from the University of Kuopio in Finland. Dr. Sen trained as a postdoctoral fellow at the University of California at Berkeley's Molecular and Cell Biology department. His first faculty appointment was in the Lawrence Berkeley National Laboratory in California. In fall of 2000, Dr. Sen moved to The Ohio State University where established a program on tissue injury and repair. Currently, Dr. Sen is a Professor and Vice Chair of Research of Surgery.

You are not allowed to post comments.